| Literature DB >> 15159170 |
Sheila Collins1, Tonya L Martin, Richard S Surwit, Jacques Robidoux.
Abstract
The development of the metabolic syndrome in an increasing percentage of the populations of Western societies, particularly in the United States, requires valid models for establishing basic biochemical changes and performing preclinical studies on potential drug targets. The C57BL/6J mouse has become an important model for understanding the interplay between genetic background and environmental challenges such as high-fat/high-calorie diets that predispose to the development of the metabolic syndrome. This review highlights metabolic and signal transduction features that are altered during the course of disease progression, many of which mirror the human situation. Copyright 2004 Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15159170 DOI: 10.1016/j.physbeh.2004.02.006
Source DB: PubMed Journal: Physiol Behav ISSN: 0031-9384